Ying Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ying Chen has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Tony Jun Huang
Thomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA
14 shared publications - Kaichun Yang
Thomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA
8 shared publications - Luke P. Lee
Renal Division and Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
8 shared publications Mingyuan Liu
Thomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA
8 shared publications- Jianping Xia
Thomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA
7 shared publications - Ke Jin
Thomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA
5 shared publications
Latest Publications
- 25 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (39)
Acoustofluidic cryo-EM enables in situ particle manipulation for uniform, high-quality cryo-EM specimens
Cryo–electron microscopy (cryo-EM) has revolutionized structural biology by enabling imaging of macromolecular complexes at near-atomic resolution, but its success depends critically on specimen quality. Standard plunge freezing often produces nonuniform particle distributions, resulting in poor particle statistics and reduced imaging quality, particularly for vesicular structures and low-concentration, labile macromolecular complexes. Here, we introduce acoustofluidic cryo-EM (ACE), a noncontact specimen-preparation method that integrates acoustofluidic manipulation into a conventional plunge-freezing workflow. ACE enables localized nanoscale particle manipulation by mechanically coupling acoustic excitation into the cryo-EM grid, where forced vibration generates localized acoustic streaming through viscous boundary-layer effects. Guided by this physical mechanism, validation using liposomes and apoferritin demonstrates that ACE increases particle density by up to fourfold while preserving structural integrity and improving imaging quality. This strategy provides a broadly applicable approach for enhancing cryo-EM specimen quality, improving imaging efficiency, and facilitating high-resolution structural analysis.
- 25 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (39)
Acoustofluidic cryo-EM enables in situ particle manipulation for uniform, high-quality cryo-EM specimens
Cryo–electron microscopy (cryo-EM) has revolutionized structural biology by enabling imaging of macromolecular complexes at near-atomic resolution, but its success depends critically on specimen quality. Standard plunge freezing often produces nonuniform particle distributions, resulting in poor particle statistics and reduced imaging quality, particularly for vesicular structures and low-concentration, labile macromolecular complexes. Here, we introduce acoustofluidic cryo-EM (ACE), a noncontact specimen-preparation method that integrates acoustofluidic manipulation into a conventional plunge-freezing workflow. ACE enables localized nanoscale particle manipulation by mechanically coupling acoustic excitation into the cryo-EM grid, where forced vibration generates localized acoustic streaming through viscous boundary-layer effects. Guided by this physical mechanism, validation using liposomes and apoferritin demonstrates that ACE increases particle density by up to fourfold while preserving structural integrity and improving imaging quality. This strategy provides a broadly applicable approach for enhancing cryo-EM specimen quality, improving imaging efficiency, and facilitating high-resolution structural analysis.
- 10 August 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 4 (10) , 1007-1023
Acoustofluidics for translational medicine
- 10 August 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 4 (10) , 1007-1023
Acoustofluidics for translational medicine
- Open Access
- 13 May 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (12) , 3617-3661
Integrated microfluidic biosensors: shaping the future of quantitative life sciences and on-chip molecular diagnostics
Integrated microfluidic biosensors have rapidly evolved into powerful platforms to meet the increasing demand for ultrasensitive and high-throughput quantitative analysis. By seamlessly combining sample handling through microfluidics with real-time detection via biosensors, these systems provide unmatched benefits in sensitivity, speed, portability, and immediate monitoring, thereby transforming diagnostics in human and animal health, environmental sensing, and point-of-care testing. In this review, we provide a comprehensive overview of integrated microfluidics with biosensors, highlighting the synergistic interplay between these two complementary fields and their various biomedical applications. We begin by examining different microfluidic technologies, including 3D dynamic cell culture systems, inertial microfluidic separation, acoustofluidics, dielectrophoresis, optofluidics, and immunoassays. Next, we discuss integrated microfluidic systems that incorporate various biosensor technologies, including electrochemical, electrophysiological, plasmonic, Raman, and quantum sensors. These are designed to detect and analyze DNA, RNA, proteins, exosomes, cells, and small organisms, covering a size range from nanometers to millimeters. Additionally, we discuss the wide range of applications for integrated microfluidic biosensors and examine significant challenges and future opportunities that will influence their ongoing development and practical use. Finally, we highlight successful commercial products developed with integrated microfluidic technologies.
- 13 May 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (12) , 3617-3661
Open AccessIntegrated microfluidic biosensors: shaping the future of quantitative life sciences and on-chip molecular diagnostics
Integrated microfluidic biosensors have rapidly evolved into powerful platforms to meet the increasing demand for ultrasensitive and high-throughput quantitative analysis. By seamlessly combining sample handling through microfluidics with real-time detection via biosensors, these systems provide unmatched benefits in sensitivity, speed, portability, and immediate monitoring, thereby transforming diagnostics in human and animal health, environmental sensing, and point-of-care testing. In this review, we provide a comprehensive overview of integrated microfluidics with biosensors, highlighting the synergistic interplay between these two complementary fields and their various biomedical applications. We begin by examining different microfluidic technologies, including 3D dynamic cell culture systems, inertial microfluidic separation, acoustofluidics, dielectrophoresis, optofluidics, and immunoassays. Next, we discuss integrated microfluidic systems that incorporate various biosensor technologies, including electrochemical, electrophysiological, plasmonic, Raman, and quantum sensors. These are designed to detect and analyze DNA, RNA, proteins, exosomes, cells, and small organisms, covering a size range from nanometers to millimeters. Additionally, we discuss the wide range of applications for integrated microfluidic biosensors and examine significant challenges and future opportunities that will influence their ongoing development and practical use. Finally, we highlight successful commercial products developed with integrated microfluidic technologies.
- Open Access
- 1 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (18) , eaee2983
Space-time acoustofluidic tweezers for dynamic and selective manipulation of microparticles
Dynamic acoustofluidics enables precise, contact-free manipulation of particles, colloids, and cells and shows great potential for applications in physics, materials science, and life sciences. However, existing strategies struggle to realize contrast-based selective manipulation primarily because the pressure fields are time invariant. Here, we introduce a space-time acoustofluidic tweezer (STAT) that uses frequency detuning–induced pseudo–space-time modulation of standing surface acoustic waves to enable dynamic, contrast-dependent control of microparticles and cells. Experiments and simulations show that, under STAT manipulation, positive (PACP) and negative (NACP) acoustic contrast particles can undergo low-frequency, shear- and longitudinal-like harmonic motions, respectively. Under certain driving conditions, NACPs can be selectively guided along programmed paths, whereas PACPs remain stably patterned. Overall, STAT offers a gentle, biocompatible way to selectively drive oscillation, transport, and sorting among particles and cells of different acoustic contrasts, broadening the capabilities of acoustofluidic systems for biomedical applications.
- 1 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (18) , eaee2983
Open AccessSpace-time acoustofluidic tweezers for dynamic and selective manipulation of microparticles
Dynamic acoustofluidics enables precise, contact-free manipulation of particles, colloids, and cells and shows great potential for applications in physics, materials science, and life sciences. However, existing strategies struggle to realize contrast-based selective manipulation primarily because the pressure fields are time invariant. Here, we introduce a space-time acoustofluidic tweezer (STAT) that uses frequency detuning–induced pseudo–space-time modulation of standing surface acoustic waves to enable dynamic, contrast-dependent control of microparticles and cells. Experiments and simulations show that, under STAT manipulation, positive (PACP) and negative (NACP) acoustic contrast particles can undergo low-frequency, shear- and longitudinal-like harmonic motions, respectively. Under certain driving conditions, NACPs can be selectively guided along programmed paths, whereas PACPs remain stably patterned. Overall, STAT offers a gentle, biocompatible way to selectively drive oscillation, transport, and sorting among particles and cells of different acoustic contrasts, broadening the capabilities of acoustofluidic systems for biomedical applications.
- Open Access
- 12 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17
Machine learning–driven design of engineered cilia enables hybrid operations in acoustic microrobots
Microrobotic systems offer significant potential for precision medicine by enabling minimally invasive interventions in complex fluidic environments. However, effective operation in these settings requires actuators capable of more than simple linear or rotational motion, often necessitating programmable changes in both direction and shape. This remains a major challenge due to fundamental constraints in the design and control of microscale actuators, particularly in acoustic systems. Here, we introduce engineered cilia for hybrid operations microrobots, a class of acoustic microrobots that use geometry-tuned cilia and resonance-induced forces to execute complex motions such as bidirectional bending, controllable rotation, and adaptive morphing. The microrobots design is driven by a self-augmenting machine learning framework integrated with finite element analysis, enabling rapid prediction and optimization of geometry-resonance relationships across design space. This approach achieves >10⁵-fold reduction in prediction time and over 20-fold in memory savings, while maintaining >90% accuracy in peak amplitude and >98% in resonance frequency. Compliant mechanism strategies further expand the mechanical versatility of the microrobots, enabling programmable shape transformations tailored to specific tasks. These advances establish acoustic-driven microrobots as a scalable and efficient platform for intelligent microrobotic actuation in biomedical and microfluidic applications.
- 12 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17
Open AccessMachine learning–driven design of engineered cilia enables hybrid operations in acoustic microrobots
Microrobotic systems offer significant potential for precision medicine by enabling minimally invasive interventions in complex fluidic environments. However, effective operation in these settings requires actuators capable of more than simple linear or rotational motion, often necessitating programmable changes in both direction and shape. This remains a major challenge due to fundamental constraints in the design and control of microscale actuators, particularly in acoustic systems. Here, we introduce engineered cilia for hybrid operations microrobots, a class of acoustic microrobots that use geometry-tuned cilia and resonance-induced forces to execute complex motions such as bidirectional bending, controllable rotation, and adaptive morphing. The microrobots design is driven by a self-augmenting machine learning framework integrated with finite element analysis, enabling rapid prediction and optimization of geometry-resonance relationships across design space. This approach achieves >10⁵-fold reduction in prediction time and over 20-fold in memory savings, while maintaining >90% accuracy in peak amplitude and >98% in resonance frequency. Compliant mechanism strategies further expand the mechanical versatility of the microrobots, enabling programmable shape transformations tailored to specific tasks. These advances establish acoustic-driven microrobots as a scalable and efficient platform for intelligent microrobotic actuation in biomedical and microfluidic applications.
- 9 January 2026
- Published by Springer Nature in Nature Protocols
- Vol. 21 (6) , 2613-2634
Acoustic separation and isolation of viruses, small extracellular vesicles and other nanoscale bioparticles
The isolation of small extracellular vesicles (sEVs), viruses and other nanoscale lipid particles from biofluids offers actionable possibilities for advancing disease diagnosis, drug delivery, regenerative medicine, personalized medicine and immunotherapy. Several methods are available to isolate sEVs from biofluids and acoustic techniques provide distinct advantages. Challenges constraining its wider application encompass the absence of adequate procedures for fabrication, implementation and performance validation. These issues impede the development of protocols applicable to nanoscale bioparticles experiencing acoustic isolation effects. Here we present a detailed protocol for acoustic separation of nanoscale bioparticles from biofluids, including plasma and saliva, achieving both high purity and throughput suitable for routine application. This protocol offers a comprehensive, step-by-step guide for the design and fabrication of the acoustic separation device, the establishment of the experimental setup and the isolation of bioparticles. To ensure reliability, rigor and reproducibility, we delineate essential procedures, including acoustic field optimization, channel fabrication and biofluid preparation, subsequently validating the protocol and its performance across different operators. Our protocol further encompasses procedures for data collection and analysis, which are essential for characterizing viruses and sEVs, as well as for evaluating their quality and integrity. This protocol enables researchers to perform high-quality isolation of nanoscale bioparticles, providing access to reliable acoustic separation techniques. Standardizing this technique will pave the way for discoveries in virology and intercellular communication research, with applications in medicine, biology, and materials science.
- 9 January 2026
- Published by Springer Nature in Nature Protocols
- Vol. 21 (6) , 2613-2634
Acoustic separation and isolation of viruses, small extracellular vesicles and other nanoscale bioparticles
The isolation of small extracellular vesicles (sEVs), viruses and other nanoscale lipid particles from biofluids offers actionable possibilities for advancing disease diagnosis, drug delivery, regenerative medicine, personalized medicine and immunotherapy. Several methods are available to isolate sEVs from biofluids and acoustic techniques provide distinct advantages. Challenges constraining its wider application encompass the absence of adequate procedures for fabrication, implementation and performance validation. These issues impede the development of protocols applicable to nanoscale bioparticles experiencing acoustic isolation effects. Here we present a detailed protocol for acoustic separation of nanoscale bioparticles from biofluids, including plasma and saliva, achieving both high purity and throughput suitable for routine application. This protocol offers a comprehensive, step-by-step guide for the design and fabrication of the acoustic separation device, the establishment of the experimental setup and the isolation of bioparticles. To ensure reliability, rigor and reproducibility, we delineate essential procedures, including acoustic field optimization, channel fabrication and biofluid preparation, subsequently validating the protocol and its performance across different operators. Our protocol further encompasses procedures for data collection and analysis, which are essential for characterizing viruses and sEVs, as well as for evaluating their quality and integrity. This protocol enables researchers to perform high-quality isolation of nanoscale bioparticles, providing access to reliable acoustic separation techniques. Standardizing this technique will pave the way for discoveries in virology and intercellular communication research, with applications in medicine, biology, and materials science.
- Top Cited PapersOpen Access
- 2 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eady1136
Precision acoustofluidics for high-throughput mechanobiology in suspension cells
Mechanomodulation, the process of altering cellular behavior through applied mechanical forces, plays a critical role in physiological processes and has substantial implications for cancer therapy, immunology, and drug development. However, precise and efficient stimulation of nonadherent cells remains a major challenge, limiting the investigation of mechanotransduction pathways and the development of targeted therapeutics. Here, we developed an acoustofluidic platform named Suspension-cell Targeted Response to Excitation via Acoustofluidic Mechanomodulation (STREAM) to enable precise, high-throughput stimulation of suspension cells. STREAM accomplishes this using 101.14-megahertz high-frequency surface acoustic waves to deliver controlled mechanical stimulation at a throughput of 500,000 cells per minute. STREAM modulates intracellular calcium ion (Ca 2+ ) signaling by activating mechanosensitive ion channels, triggering mitochondrial membrane disruption and tunable K562 leukemia cell apoptosis rates from 5.15 to 47.1%. STREAM provides a scalable, precise tool for studying mechanotransduction in suspension cells, with broad applications in cancer research, immunotherapy, and high-throughput drug screening.
- 2 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eady1136
Top Cited PapersOpen AccessPrecision acoustofluidics for high-throughput mechanobiology in suspension cells
Mechanomodulation, the process of altering cellular behavior through applied mechanical forces, plays a critical role in physiological processes and has substantial implications for cancer therapy, immunology, and drug development. However, precise and efficient stimulation of nonadherent cells remains a major challenge, limiting the investigation of mechanotransduction pathways and the development of targeted therapeutics. Here, we developed an acoustofluidic platform named Suspension-cell Targeted Response to Excitation via Acoustofluidic Mechanomodulation (STREAM) to enable precise, high-throughput stimulation of suspension cells. STREAM accomplishes this using 101.14-megahertz high-frequency surface acoustic waves to deliver controlled mechanical stimulation at a throughput of 500,000 cells per minute. STREAM modulates intracellular calcium ion (Ca 2+ ) signaling by activating mechanosensitive ion channels, triggering mitochondrial membrane disruption and tunable K562 leukemia cell apoptosis rates from 5.15 to 47.1%. STREAM provides a scalable, precise tool for studying mechanotransduction in suspension cells, with broad applications in cancer research, immunotherapy, and high-throughput drug screening.
- Open Access
- 19 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (51) , eaeb0879
Programmable acoustofluidic engineering for creating gradient biomaterials
Gradient biomaterials that exhibit spatially varying physical, chemical, or biological properties can be used in various applications such as tissue engineering, organoid development, mechanobiology, and spatially controlled drug delivery. However, current fabrication methods often suffer from limited gradient precision, restricted material compatibility, and poor reproducibility. Here, we introduced gradient regulation via acoustofluidic dynamic engineering (GRADE), a programmable system to generate high-fidelity gradient biomaterials across different material systems. By incorporating focused interdigital transducers with the pulsed surface acoustic wave actuation, GRADE can achieve tunable and directional acoustic streaming (0 to 22 millimeters per second), which allows accurate regulation of the gradient magnitude and length. Its open microchannel design enables nondestructive extraction of centimeter-scale gradients and supports device reuse, enhancing practicality and scalability. In contrast to magnetic or electrospinning techniques that are limited to specific material types, the GRADE approach supports composition-independent fluid manipulation of a diverse group of biomaterials and cross-linking methods, thus providing greater versatility and translational potential. Furthermore, we demonstrate stiffness-dependent mechanosensation in stem cells cultured on customized gradient substrates, which validates the platform’s usability. The experimental results show that GRADE has the ability to uncover mechanobiological responses in physiologically relevant contexts. All these results establish GRADE as a powerful and versatile platform for gradient biomaterial fabrication. It shows broad potential to advance both fundamental research and translational biomedical applications.
- 19 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (51) , eaeb0879
Open AccessProgrammable acoustofluidic engineering for creating gradient biomaterials
Gradient biomaterials that exhibit spatially varying physical, chemical, or biological properties can be used in various applications such as tissue engineering, organoid development, mechanobiology, and spatially controlled drug delivery. However, current fabrication methods often suffer from limited gradient precision, restricted material compatibility, and poor reproducibility. Here, we introduced gradient regulation via acoustofluidic dynamic engineering (GRADE), a programmable system to generate high-fidelity gradient biomaterials across different material systems. By incorporating focused interdigital transducers with the pulsed surface acoustic wave actuation, GRADE can achieve tunable and directional acoustic streaming (0 to 22 millimeters per second), which allows accurate regulation of the gradient magnitude and length. Its open microchannel design enables nondestructive extraction of centimeter-scale gradients and supports device reuse, enhancing practicality and scalability. In contrast to magnetic or electrospinning techniques that are limited to specific material types, the GRADE approach supports composition-independent fluid manipulation of a diverse group of biomaterials and cross-linking methods, thus providing greater versatility and translational potential. Furthermore, we demonstrate stiffness-dependent mechanosensation in stem cells cultured on customized gradient substrates, which validates the platform’s usability. The experimental results show that GRADE has the ability to uncover mechanobiological responses in physiologically relevant contexts. All these results establish GRADE as a powerful and versatile platform for gradient biomaterial fabrication. It shows broad potential to advance both fundamental research and translational biomedical applications.
- Open Access
- 21 October 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (23) , 6314-6323
Enhancing cancer therapy via acoustics: chemotherapy-enhanced tunable acoustofluidic permeabilization (ChemoTAP)
A chemo-acoustic tumor stimulation system amplifies cisplatin-induced apoptosis by elevating ROS levels via mechanical modulation.
- 21 October 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (23) , 6314-6323
Open AccessEnhancing cancer therapy via acoustics: chemotherapy-enhanced tunable acoustofluidic permeabilization (ChemoTAP)
A chemo-acoustic tumor stimulation system amplifies cisplatin-induced apoptosis by elevating ROS levels via mechanical modulation.
- Open Access
- 5 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (36) , eady3262
Acoustofluidic system for targeted antibody removal in transplantation: Enabling small-volume therapeutic apheresis
Antibody-mediated rejection is a leading cause of allograft failure and mortality in pediatric solid organ transplant recipients. Current apheresis systems require large blood volumes and are primarily designed for adults, making them unsuitable for children and small animals. These systems often indiscriminately remove both harmful and protective antibodies, increasing the risk of complications such as life-threatening infections. To address this critical need, we developed acoustofluidic-based system for targeted antibody removal in transplantation (A-START). A-START is engineered to handle small blood volumes and has demonstrated efficacy in preclinical small animal trials. In a sensitized rodent skin transplantation model, A-START only demands 240 microliters of blood, selectively removing donor-specific alloantibodies (DSAs) while preserving protective antibodies, such as tetanus antibodies. A-START retains ~95% of beneficial antibodies and achieves a 60% improvement in DSA removal compared to conventional methods. These findings highlight the transformative potential of A-START as a promising, reliable, scalable solution for improving outcomes in pediatric transplantation and treating antibody-mediated diseases.
- 5 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (36) , eady3262
Open AccessAcoustofluidic system for targeted antibody removal in transplantation: Enabling small-volume therapeutic apheresis
Antibody-mediated rejection is a leading cause of allograft failure and mortality in pediatric solid organ transplant recipients. Current apheresis systems require large blood volumes and are primarily designed for adults, making them unsuitable for children and small animals. These systems often indiscriminately remove both harmful and protective antibodies, increasing the risk of complications such as life-threatening infections. To address this critical need, we developed acoustofluidic-based system for targeted antibody removal in transplantation (A-START). A-START is engineered to handle small blood volumes and has demonstrated efficacy in preclinical small animal trials. In a sensitized rodent skin transplantation model, A-START only demands 240 microliters of blood, selectively removing donor-specific alloantibodies (DSAs) while preserving protective antibodies, such as tetanus antibodies. A-START retains ~95% of beneficial antibodies and achieves a 60% improvement in DSA removal compared to conventional methods. These findings highlight the transformative potential of A-START as a promising, reliable, scalable solution for improving outcomes in pediatric transplantation and treating antibody-mediated diseases.